Abstract:Generation of hiPSCs with multi‐gene modifications, including motor neuron‐specific transcription factors Ngn2, Isl1, and Lhx3 controlled by Tet‐On system and one anti‐apoptosis gene Bcl‐xL. The genetically modified hiPSCs survived and directionally differentiated into motor neurons after transplantation in vivo. The genetically modified hiPSCs partially converted into neural progenitors, serving as a spare cell resource. Objectives Transplantation of neural progenitor cells (NPCs) derived from human‐induced pluripotent stem cells (hiPSCs) is one of the promising treatment strategies for motor neuron diseases (MNDs). However, the inefficiency in committed differentiation of NPCs in vivo limits its application. Here, we tried to establish a potential therapeutic strategy for MNDs by in vivo directional differentiation of hiPSCs engineered with motor neuron (MN) specific transcription factors and Tet‐On system. Materials and Methods We engineered hiPSCs with three MN‐specific transcription factors and Tet‐On system. The engineered cells were directly transplanted into immunodeficient mice through subcutaneous, intra‐spinal cord and intracerebroventricular injections. Following doxycycline (Dox) induction, teratoma formation, and motor MN differentiation were evaluated. Results We generated genetically engineered hiPSCs, in which the expression of Ngn2, Isl1, and Lhx3 was controlled by a drug‐inducible transgenic system. These cells showed normal pluripotency and proliferative capacity, and were able to directionally differentiate into mature motor neurons (MNs) and NPCs with high efficiency in spinal cords and cerebral lateral ventricles under the induction of Dox. The grafts showed long‐term survival in the recipient mice without formation of teratoma. Conclusions The induced mature MNs and NPCs were expected to replace the damaged endogenous MNs directly, and play a role of de novo stem cell stock for long‐term neuron damage repair, respectively. Therefore, in vivo directional differentiation of the hiPSCs engineered with MN‐specific transcription factors and Tet‐On system via Dox induction could be a potential therapeutic strategy for MNDs with high efficacy and safety.

Direct conversion of urine-derived cells into functional motor neuron-like cells by defined transcription factors

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Conversion of Human Urine Cells to Neurons by Small Molecules

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Chemical Conversion of Human and Mouse Fibroblasts into Motor Neurons

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct Conversion of Mouse Fibroblasts to Gabaergic Neurons with Combined Medium Without the Introduction of Transcription Factors or Mirnas

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Direct conversion of adipocyte progenitors into functional neurons.

Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons

Direct Conversion of Cord Blood CD34+ Cells into Neural Stem Cells by OCT4

Transcription Factor-Mediated Differentiation of Motor Neurons from Human Pluripotent Stem Cells

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Inducible motor neuron differentiation of human induced pluripotent stem cells in vivo

High-efficiency Motor Neuron Differentiation from Human Pluripotent Stem Cells and the Function of Islet-1

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Rapid and Efficient Generation of Functional Motor Neurons from Human Pluripotent Stem Cells Using Gene Delivered Transcription Factor Codes.